## **Core Concept**
Hemophilia is a genetic disorder characterized by the deficiency of **clotting factors**, primarily **Factor VIII** (Hemophilia A) or **Factor IX** (Hemophilia B). Screening tests for hemophilia aim to identify abnormalities in the coagulation pathway. The most commonly used screening tests include **Prothrombin Time (PT)**, **Activated Partial Thromboplastin Time (aPTT)**, and **Bleeding Time**.

## **Why the Correct Answer is Right**
The best screening test for hemophilia is **Activated Partial Thromboplastin Time (aPTT)**. This is because hemophilia A and B result from deficiencies of factors VIII and IX, respectively, which are part of the **intrinsic and common coagulation pathways**. The aPTT test evaluates the integrity of these pathways. An **aPTT prolongation** suggests a problem in the intrinsic pathway, which includes factors VIII, IX, XI, and XII, making it a sensitive indicator for hemophilia.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Prothrombin Time (PT) is primarily used to assess the **extrinsic and common coagulation pathways**. It is not the best screening test for hemophilia because it does not directly evaluate the intrinsic pathway where factors VIII and IX are involved.
- **Option C:** Bleeding Time assesses **platelet function** and the body's ability to form a platelet plug. It is not specific for diagnosing coagulation factor deficiencies like hemophilia.
- **Option D:** While specific tests like **Factor VIII and IX assays** can diagnose hemophilia by quantifying the levels of these factors, they are not screening tests but rather **confirmatory tests**.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that an isolated **aPTT prolongation** should prompt investigation for hemophilia A or B, especially in patients with a history of easy bruising, joint pain (suggestive of hemarthrosis), or prolonged bleeding after trauma or surgery.

## **Correct Answer:** B. aPTT